GLP-1 agonist treatment significantly improved the glycemic control in a patient with a dominant form of Wolfram syndrome, suggesting that treatment with these drugs should also be considered in patients with dominant forms of Wolfram syndrome (Scully and Wolfsdorf, 2020). Here, GCG is linked to Wolfram syndrome.